Sanara MedTech Bolsters Executive Leadership with Strategic Appointments

Sanara MedTech Inc. (SMTI), a leading medical technology company focused on improving clinical outcomes and reducing healthcare expenditures, has expanded its executive leadership team with two strategic appointments. Elizabeth Taylor has been named Chief Financial Officer (CFO), while Michael McNeil transitions to the roles of Chief Accounting Officer and Chief Administrative Officer. These appointments, effective as of January 15, 2025, aim to strengthen Sanara's financial management and support its continued growth and development.

Elizabeth Taylor brings over 25 years of financial experience to her new role, with a career history that includes serving as CFO of a medical device company focused on wound treatment, Chief Operating Officer of multiple hedge funds, and as a member of the investment team at a leading private equity firm. Her diverse background, which combines industry and Wall Street experience, will complement the strengths of Sanara's existing finance and accounting teams. Taylor's expertise in budgeting, forecasting, and financial analysis, honed during her tenure at Imbed Biosciences, will be invaluable in supporting Sanara's next phase of growth.

Michael McNeil, the former CFO, will now lead financial reporting and accounting policy as Chief Accounting Officer and Chief Administrative Officer. His deep understanding of Sanara's financial landscape, gained through his previous role, will ensure continuity and consistency in the company's financial reporting processes. McNeil's experience and expertise in financial reporting and accounting will be crucial in maintaining the accuracy and reliability of Sanara's financial reporting, as well as strengthening its internal controls and compliance.

The appointments of Elizabeth Taylor and Michael McNeil reflect Sanara's commitment to strategic growth and development. Taylor's industry and Wall Street experience will be instrumental in driving market penetration and expansion in the surgical, chronic wound, and skincare markets. Meanwhile, McNeil's expertise in financial reporting and accounting will ensure that Sanara's financial operations remain robust and efficient, supporting the company's overall growth and success.



In addition to these strategic appointments, Sanara has made significant progress in its operational and financial performance. The company reported preliminary results for the fourth quarter and full year ended December 31, 2024, with net revenue expected to increase by 45% to 48% year-over-year in the fourth quarter and 32% to 33% year-over-year for the full year. These strong results are a testament to Sanara's growth strategy and the execution of its leadership team.



In conclusion, Sanara MedTech Inc.'s expansion of its executive leadership team with the appointments of Elizabeth Taylor as CFO and Michael McNeil as Chief Accounting Officer and Chief Administrative Officer demonstrates the company's commitment to strategic growth and development. With their combined expertise and experience, Taylor and McNeil will be instrumental in driving Sanara's continued success in the medical technology industry.